Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Is Gearing Up For Interim HCV Release Next Month

- August 12, 2016
GlaxoSmithKline Plc

NeRRe, A GlaxoSmithKline Plc (NYSE:GSK) Spinout Raises £23 Million For NK Antagonists

Novartis

Novartis AG (ADR) (NYSE:NVS) And Bristol-Myers Squibb Co (NYSE:BMY) Team Up On Cancer Treatment

Mylan N.V. (NASDAQ:MYL) Says It Disagrees With FDA Decision On Generic Form of Advair

Reliq Health Technologies Expands Leadership Team As Investigations Continue

VIVUS, Inc. (NASDAQ:VVUS) Settles With Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)...

- July 7, 2017 0
Medtronic PLC

Medtronic plc. (NYSE:MDT), Mercy Ink Deal For Data Network

- October 16, 2017 0
Pfizer Inc (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) To Cut Off 150 Jobs At its New...

Andy Parker - August 3, 2016 0
sanofi sny

Sanofi SA (NYSE:SNY) Introduces Major Executive change

- May 24, 2016 0

Sanofi SA (NYSE:SNY) Keeps Tab Of The Launch Of Dengvaxia

Andy Parker - September 13, 2016 0

Two Companies To Watch This Week: Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) And...

- January 3, 2018 0
FDA

What Should the FDA do With Sarepta Therapeutics Inc’s (NASDAQ:SRPT) Eteplirsen?

- April 26, 2016 0

How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto...

Andy Parker - June 23, 2016 0
vertex

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Update Reinforces Cystic Fibrosis Dominance

- April 28, 2016 0
ARCA

Biotech Movers: Argenx (NASDAQ:ARGX) and Blueprint Medicines Corporation (NASDAQ:BPMC).

- December 13, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 4, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 15, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 8, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019